SCHEMBL3153242

SCHEMBL3153242

COC(C)=C1C(=O)Nc2cc(C(N)=O)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.41
CHEK1 O14757 4/20 0.40
IDO1 P14902 2/20 0.39
PDPK1 O15530 3/20 0.39
KDR P35968 2/20 0.37
FLT3 P36888 2/20 0.37
GSK3A P49840 2/20 0.37
GSK3B P49841 2/20 0.37
CDK5 Q00535 2/20 0.37
IRAK4 Q9NWZ3 2/20 0.37
ROCK2 O75116 1/20 0.37
CSF1R P07333 1/20 0.37
ROCK1 Q13464 1/20 0.37
SLK Q9H2G2 1/20 0.37
MKNK2 Q9HBH9 2/20 0.37
AKT1 P31749 2/20 0.37
PLK4 O00444 1/20 0.37
MAPK13 O15264 1/20 0.37
DAPK3 O43293 1/20 0.37
DYRK3 O43781 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3153235 1.00 TDP1 (0.41) TDP1CHEK1IDO1PDPK1KDR
SCHEMBL3156400 0.82 IDO1 (0.42) TDP1CHEK1IDO1PDPK1KDR
SCHEMBL3156413 0.82 IDO1 (0.42) TDP1CHEK1IDO1PDPK1KDR
SCHEMBL3157673 0.80 IDO1 (0.38) TDP1CHEK1IDO1PDPK1KDR
SCHEMBL3157684 0.80 IDO1 (0.38) TDP1CHEK1IDO1PDPK1KDR
SCHEMBL2568579 0.80 KMT2A (0.49) TDP1PDPK1AKT1KMT2ACTDSP1
SCHEMBL2568583 0.80 KMT2A (0.49) TDP1PDPK1AKT1KMT2ACTDSP1
SCHEMBL7490151 0.77 BACE1 (0.42) PDPK1AKT1PIM1CSNK2A1CA2
SCHEMBL2572023 0.77 BACE1 (0.42) PDPK1AKT1PIM1CSNK2A1CA2
SCHEMBL2572027 0.77 BACE1 (0.42) PDPK1AKT1PIM1CSNK2A1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224170-B9 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA (DE) 2017-11-22 EP disclosed
EP-2157081-A1 Indolinones substituted in six locations, their manufacture and their application as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2010-02-24 EP disclosed
US-6762180-B1 Substituted indolines which inhibit receptor tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-07-13 US disclosed